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ABSTRACT

Several series of polyurethanes were synthesized with linear or crosslinked
structures by using different synthesis routes. Two studies are mentioned: (1) the
synthesis of degradable polyurethanes with linear structure and the investigation of the
elasticity and cytophilicity of the materials as function of the chain extender, and (2) the
synthesis and the investigation of the biocompatibility, degradation, hydrophilicity and
mechanical properties of the polyurethane-based hydrogels with crosslinked structure.
In the first study, two types of biodegradable polyurethanes (PUs) were
synthesized from methylene di-p-phenyl-diisocyanate (MDI), polycaprolactone diol
(PCL-diol), and chain extenders of either butanediol (BD) or 2,2 -(methylimino)diethanol
(MIDE). The effects of two types of chain extenders on the degradation, mechanical
properties, hydrophilicity, and cytophilicity of PUs were evaluated. In this study, we
concluded that by changing the type of chain extender used during the synthesis of
degradable PUs, the degradation rate, mechanical properties, hydrophilicity, and
cytophilicity could be tailored for biomedical applications in different tissues.
In the second study, a series of degradable polyurethane based light-curable
elastic hydrogels were synthesized from polycaprolactone diol (PCL-diol), polyethylene
glycol (PEG), lysine diisocyanate (LDI), and 2-hydroxyethyl methacrylate (HEMA)
through UV light initiated polymerization reaction. The use of PCL/PEG at different
ratios, as well as the introduction of HEMA into polyurethane, allows the synthesis of a
series of biocompatible elastic hydrogels with tunable physical and cytophilic properties.
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This series of materials also allows for controlling cell attachment and growth by
incorporating bioactive molecules during the light-curing process.
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CHAPTER 1
THESIS ROADMAP
Abstract
This thesis constitutes studies of the materials research of several novel
polyurethanes with potential for biomedical use. Several series of polyurethanes were
synthesized with linear or crosslinked structures by using different synthesis routes. This
thesis includes two studies: (1) the synthesis of degradable polyurethanes with linear
structure and the investigation of the elasticity and cytophilicity of the materials by
changing chain extender, and (2) the synthesis of the polyurethane-based hydrogels with
crosslinked structure and the investigation of the biocompatibility, degradation,
hydrophilicity and mechanical properties.
In the first part of this thesis, two types of biodegradable polyurethanes (PUs)
were synthesized from methylene di-p-phenyl-diisocyanate (MDI), polycaprolactone diol
(PCL-diol), and chain extenders of either butanediol (BD) or 2,2 -(methylimino)diethanol
(MIDE). The effects of two types of chain extenders on the degradation, mechanical
properties, hydrophilicity, and cytophilicity of PUs were evaluated. In this study, we
concluded that by changing the type of chain extender used during the synthesis of
degradable PUs, the degradation rate, mechanical properties, hydrophilicity, and
cytophilicity could be adjusted for biomedical applications in different tissues.
In the second part of this thesis, a series of degradable polyurethane based
light-curable elastic hydrogels were synthesized from polycaprolactone diol (PCL-diol),
polyethylene glycol (PEG), lysine diisocyanate (LDI), and 2-hydroxyethyl methacrylate
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(HEMA) through UV light initiated polymerization reaction. In this study, the use of
PCL/PEG at different ratios, as well as the introduction of HEMA into polyurethane,
allows the synthesis of a series of biocompatible elastic hydrogels with tunable physical
and cytophilic properties through light initiated polymerization. This series of materials
also allows for controlling cell attachment and growth by incorporating bioactive
molecules during the light-curing process.
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CHAPTER 2
BACKGROUND
Introduction of Biomaterials and Scaffolds
The destruction or malformation of tissues and organs can be caused by trauma,
primary disease or by medical intervention and treatment modalities. [1] A large part of
modern medical practice targets the restoration of function by replacement of damaged or
diseased tissues and organs, the replacement is by either artificial implants or
transplantation of tissues. [2] Such interventions are hindered by factors such as immune
rejection, limited supply and donor site morbidity.
In recent decades, tissue engineering has emerged as an alternative method for the
regeneration of tissues and restoration of function of organs through implantation of
cells/tissues grown outside the body or stimulating cell to grow into an implanted
matrix.[3] While initial biomaterials were commonly inert, biomaterial research then
focused on the bioactive materials that elicit action and reaction in the biological
environment. Today, there is a move to new generation of materials to repair or replace
diseased or damaged tissue, using controlled three-dimensional scaffolds in which cells
can be seeded usually before implantation. The materials and scaffold can stimulate
specific cellular response at the molecular level; they are also biodegradable and can be
tailored to suit specific tissues. Ideally, the living tissue construct is functionally,
structurally and mechanically equal to the tissue it has been designed to replace.[4]
There are a number of materials used for tissue engineering application; the
materials can be subdivided into natural materials and synthetic materials. Examples of
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natural materials include collagen, glycosaminoglycans (GAGs), chitosan and alginates.
[5-8] The advantages of natural materials are that they have low toxicity and a low
chronic inflammatory response. They can be combined into a composite with other
natural materials or synthetic materials (thus possessing the mechanical strength of the
synthetic material as well as the biocompatibility of the natural material) and can be
degraded by naturally occurring enzymes. However, disadvantages include poor
mechanical strength as well as a complex structure and, hence, manipulation becomes
more difficult. They can easily be denatured and often require chemical modification,
which can lead to toxicity. Examples of synthetic materials include the biodegradable
polymers such as polyglycolide (PGA), polylactide (PLA) and polylactide-co-glycolide
(PLG); non-degradable polymers such as polytetrafluoroethylene (PTFE), nylon and
polyethylene terephthalate (PET); ceramics such as single crystal Al2O3 and
polycrystalline Al2O3; bioactive glasses such as Bioglass (US Biomaterials).[9-13]
Techniques used to manufacture biomaterials into scaffolds are dependent on the
properties of the material and its intended application. Scaffolds may be composed of
polymers, metals, ceramics or composites. It is important to select a material that closely
matches the properties of the tissue that it is to replace. For example, biomaterials
intended to replace soft tissues such as skin, breast, eye, blood vessels and heart valves
tend to be composed of natural and synthetic polymers. Replacement of hard tissues such
as bone and dentine tends to use metals, ceramics, composites and polymers.[3, 14-18]
For the three-dimensional scaffold with cells seeded before implantation, the clinical
success of the scaffold is also largely dependent on the suitable supply of cells in the
scaffold. There are a number of different sources of cells that could be used for tissue
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repair and regeneration, including mature cells from the patient, ‘adult’ stem cells from
the patient such as bone marrow stromal stem cells, and embryonic stem (ES)
cells/embryonic germ (EG) cells.[19-21]
Introduction of Polyurethanes
Polyurethanes form a large family of polymeric materials with an enormous
diversity of chemical composition and properties. These properties have contributed to
their widespread application in many areas and use in a range of commodity products,
such as polymers for clothing, automotive parts, furnishings, construction and paints for
appliances. Compared to most polymers manufactured in industry, polyurethanes possess
more complex chemical structures, typically comprising three monomers: a diisocyanate,
a macroglycol, and a chain extender. These three parts in the polyurethane structure,
enable one to create a virtually infinite number of materials with various physicochemical
and mechanical characteristics. This unique composition makes the structure of
polyurethanes quite different from that of other polymers. In fact, polyurethane polymers
usually show a two-phase structure in which hard segment-enriched domains are
dispersed in a matrix of soft segments. The hard segment-enriched domains are
composed mainly of the diisocyanate and the chain extender, while the soft segment
matrix is composed of a sequence of macroglycol moieties. For this reason,
polyurethanes are often referred to as segmented block copolymers. This particular
molecular architecture, as well as the intrinsic properties of each ingredient used for the
synthesis of polyurethanes, contributes to the unique characteristics of this class of
materials when compared to other polymers. [22]
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Generally, there are three methods for the preparation of polyurethanes: the
one-shot method, the prepolymer method, and the quasi-prepolymer method. [23-27] The
prepolymer method and the quasi-prepolymer method are regrouped as ‘two-step
methods’ or ‘two-step polymerization’. In the one-shot method, all the ingredients are
mixed simultaneously and the resulting mixture is directly allowed to polymerize. In the
prepolymer method, the macroglycol is pre-reacted with an excess of poly-isocyanate.
This prepolymer is then mixed with the rest of the ingredients during processing. In the
quasi-prepolymer method, a part of the macroglycol is mixed with the poly-isocyanate
and the rest of the polymer and the other constituents are mixed as a second phase. The
streams thus obtained are finally mixed together at the end. Those final polyurethanes can
be further categorized into two broad groups: thermoplastics and thermosets.
Thermoplastics are defined as materials capable of being repeatedly softened by heat and
hardened by cooling. Thermosets, on the contrary, are set into permanent shape by
chemical crosslinking that occurs during or after forming. Once a thermoset has been
hardened into the desired shape, the process is generally irreversible. In the case of
polyurethanes synthesized in our laboratory, both thermoplastic and thermoset
polyurethanes were obtained.
Polyurethanes exhibit many excellent properties for biomedical applications. For
instance, one of the characteristic properties of polyurethanes is their mechanical
flexibility combined with high tear strength, which can be achieved because of
polyurethane’s chemical versatility. These desirable properties attract the attention of
developers of biomedical devices. In 1958, polyurethane materials were first introduced
in biomedical applications; Pangman described a composite breast prosthesis covered
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with a polyester-urethane foam. [28, 29] In the same year, Mandrino and Salvatore also
used a rigid polyester-urethane foam called OstamerTM for in situ bone fixation. [30-33]
Three years later, the application of polyester-urethane Polyurethane Estane® VC was
proposed by Dreyer et al to be used as components for heart valves and chambers, and
aortic grafts.[34, 35] In the mid-1960s, Cordis Corp. started to commercialize
polyester-urethane diagnostic catheters.[36] In 1954, textile chemists at DuPont
developed Lycra® spandex as a high-performance alternative to natural rubber in elastic
thread. It was first introduced as a biomaterial in 1967 by Boretos and Pierce who
obtained the polymer in solution directly from the DuPont spinning line that produced
Lycra spandex yarn. This material was first used as the elastomeric components of a
cardiac assist pump and its arterial cannulae.[37-39] The year 1971 marked the arrival of
the earliest polyurethane specifically designed for medical use; Avcothane-51TM, a
polyurethane/slicone hybrid, was invented by AVCO-Everett Research Laboratory. In
1972, BiomerTM, a version of Lycra® T-126 produced by Ethicon Corp. under a license
from Dupont, was made available. Avcothane and Biomer were regarded as the first
‘real’ biomedical polyurethanes and have been studied intensively. Avcothane was used
clinically in the first intra-aortic balloon pump (IAB), starting in about 1971, and is still
in clinical use today in IABs. BiomerTM components were used in the ‘Jarvik Heart’ in
1982, the first artificial heart used for implantation. From that time, the research of
polyurethanes in biomedical applications has been intensive, and currently polyurethanes
have been applied in a number of biomedical tissue engineering areas such as pacemaker
lead insulators, heart valves, vascular protheses, breast implants, gastric bubbles, drug
release carriers, etc.[40-49]
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While traditionally investigators have used polyurethanes as long-term implant
materials [50] and have attempted to shield them from the biodegradation processes,
recent work by investigators has utilized the flexible chemistry and diverse mechanical
properties of polyurethane materials to design degradable polymers for applications as
varied as neural conduits [51] to bone replacements.[52-55] These materials have for the
most part taken advantage of hydrolytic mechanisms and have varied molecular
structures to control rates of hydrolysis.[56]
The move to degradable polyurethane-based materials has required a change in
the diisocyanates historically used for their synthesis. Generally, an aromatic diisocyanate
was used for applications where degradation was not desired, such as pacemaker lead
coverings, catheters, and wound dressings.[50] Partially because of the putative
carcinogenic nature of aromatic diisocyanates,[57, 58] degradable polyurethanes are
more frequently made from diisocyanates such as lysine-diisocyanate (LDI, 2,6
diisocyanato methyl caproate),[54, 59, 60] hexamethylene diisocyanate,[55, 61] and 1,4
diisocyanatobutane

whose ultimate degradation products are more likely to be

non-toxic and biocompatible. [61]
Modification of the degradation rate is typically achieved through changes to he
soft segment, and biodegradable PUs have been made using a variety of soft segments
including polylactide or polyglycolic acid,[62-64] polycaprolactone (PCL), [51-55, 61]
and polyethylene glycol (PEG). [53-55]
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CHAPTER 3
RESEARCH OBJECTIVES
Polyurethanes have great promise for biomedical applications due to their
excellent mechanical properties and great chemical versability. The majority of research
on biomedical polyurethanes in the past was focused on the development of
nondegradable polyurethanes. In recent years, the study of degradable polyurethanes has
examined its application in both hard tissue and soft tissue regeneration. Among the
degradable polyurethanes, only few thermoplastic polyurethanes have been intensively
investigated. To broaden the biomedical application of polyurethanes, our objective is not
only to develop a series of thermoplastic (linear) but also thermoset (crosslinked
structure) polyurethanes with adjustable degradation, cytophilicity and hydrophilicity.
The research here is to study the properties of linear polyurethane as function of different
chain extender during synthesis; furthermore, the properties of crosslinked polyurethanes
as function of the soft segment will be highlighted. Our preliminary research on
biomedical polyurethanes is addressed in this thesis.
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PART I: CHAPTER 4
IMPROVING THE ELASTICITY AND CYTOPHILICITY OF BIODEGRADABLE
POLYURETHANE BY CHANGING CHAIN EXTENDER
Abstract
Two types of biodegradable polyurethanes (PUs) were synthesized from
methylene di-p-phenyl-diisocyanate (MDI), polycaprolactone diol (PCL-diol), and chain
extenders of either butanediol (BD) or 2,2-(methylimino)diethanol (MIDE). The effects
of two types of chain extenders on the degradation, mechanical properties, hydrophilicity,
and cytophilicity of PUs were evaluated. In vitro degradation studies showed that PU
containing MIDE has a higher degradation rate than PU synthesized using BD as a chain
extender. Mechanical testing on dry and wet samples demonstrated that PU containing
MIDE has a much higher elongation in the elastic region than PU containing BD. PU
containing MIDE is more hydrophilic and retains more liquid during in vitro culture.
Furthermore, preliminary cytocompatibility studies showed that both types of degradable
PU are nontoxic, and fibroblasts adhere better and proliferate faster on MIDE containing
PU than BD containing PU. To compare the cytocompatibility and degradation behaviors
of the synthesized PU with existing FDA approved biocompatible material, polylactide
(PLA), with a similar degradation rate, was used as negative control. Two types of PU
were shown to have similar cytocompatibility and degradation behaviors as those of the
PLA material. To verify the effectiveness of the cytotoxicity assay, latex was used as a
positive control. Latex samples showed toxicity to cultured cells as expected. In
conclusion, by changing the type of chain extender used during the synthesis of
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degradable PUs, the degradation rate, mechanical properties, hydrophilicity, and
cytophilicity can be adjusted for different tissue engineering applications.
Introduction
Biocompatible polymers are extensively investigated for applications in tissue and
organ repair. More and more studies are focused on using biodegradable polymers for
tissue engineering purposes, because nondegradable polymers may become detrimental
due to their impediment of graft-host integration, mechanical impingement, and
long-term foreign body reactions.[1-4] Many different categories of biodegradable
polymers, including both natural and synthetic, have been used for tissue repair purposes,
including collagen, chitosan, hyaluronic acid (HA), polyester, polyanhydride,
polycarbonate, polyimide, polyamide, poly(amino acid), polyphosphazene, and so
forth.[5-14] Although most of the currently investigated degradable polymers are well
tolerated by cells in culture and in tissues, the mechanical properties of these polymers
are not compatible with natural tissues. For example, most natural tissues, such as heart,
blood vessels, skeletal muscle, tendon, and so forth, are very elastic and strong. The
majority of degradable polymers are either too stiff/brittle with low elongation, or very
soft with relatively low strength. With the increasing interest in engineering various
tissues for the treatment of many types of injuries and diseases, a wide variety of
degradable polymers with desirable mechanical, degradation, and cytophilic properties
are needed. Because of its excellent mechanical properties and great chemical
versatility,[15-22] elastic degradable PU shows promise as being a good candidate for
most soft tissue regeneration, such as cardiac muscle,[23] blood vessel,[19, 24] skeletal
muscle, tendon, ligament, and skin repair. In addition, elastic degradable PU is also
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investigated for hard tissue regeneration, such as cartilage [22] and bone tissue repair.[21,
25] However, the majority of investigations in the past were focused on the development
of nondegradable PUs for long-term implantation, such as pacemaker lead insulators,
catheters, cardiovascular grafts, and so forth.[26] Relatively few investigations had been
directed toward developing degradable PUs.[15-25, 27-31] Moreover, control of the
degradation rate and cytophilicity of PUs has not been well studied. Different degradation
profiles are required to promote the regeneration of specific tissues.[32-34] For example,
if the degradation rate is too fast, the regenerated tissue may be exposed to physiological
load too early as in bone, muscle, tendon, and ligament tissue repair, resulting in failure
of the implants. If the degradation rate is too slow, stress shielding may occur on
regenerating tissues and chronic inflammation may also be exaggerated.[32, 35, 36] To
this end, this study is aimed at developing degradable PU with adjustable mechanical
properties, degradation behaviors, and biocompatibility. Based on the fact that
crystallinity, hydrophilicity, and so forth, may affect the mechanical properties,
cytocompatibility, and degradation profile of the degradable polymers, the hypothesis of
this study is that the mechanical properties, degradation profile, and cytophilicity of the
degradable PU can be adjusted using a chain extender with more polarized, hydrophilic,
and flexible characteristics. To this end, the effect of chain extenders on the properties of
biodegradable PU was investigated. Methylene di-p-phenyl-diisocyanate (MDI) and
polycaprolactone (PCL) based PU was used as a model degradable PU system; and
butanediol (BD) and 2,2 -(methylimino)diethanol (MIDE) were utilized as two model
chain extenders in this study. The effects of two types of chain extenders on the
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degradation, mechanical property, hydrophilicity, and cytophilicity of degradable PUs
were evaluated.

Materials and Methods

Materials

Methylene di-p-phenyl-diisocyanate (MDI), butanediol (BD), 2,2-(methylimino)
diethanol (MIDE), and N,N-dimethylformamide (DMF) were obtained from Acros
Organics Fine Chemicals (Geel, Belgium). Stannous octoate (Sn(oct)2,
Sn[CH3(CH2)3CH(C2H5)COO]2) and polycaprolactone diol (PCL-diol) with Mn = 530
were purchased from Sigma-Aldrich (St. Louis, MO). MDI was purified through vacuum
distillation, while BD was distilled with calcium hydrogen in a vacuum to eliminate
moisture. DMF was distilled over calcium hydrogen at atmospheric pressure under
nitrogen protection. PCL530 was dehydrated in a vacuum oven at 60°C for 48 h. Sn(oct)2
was purified by 4 Å molecular sieve with stirring overnight to get rid of the trace water
prior to use.

Synthesis of Degradable PUs

Degradable PUs were synthesized using a two-step method.[35] Briefly, the
stoichiometry of the PU synthesis reaction was approximately 2:1:1 of hard segment
(diisocyanate)/soft segment (PCL-diol)/chain extender. The MDI was dissolved in 50 mL
DMF and PCL-diol was added dropwise into the MDI solution. This mixture was allowed
to react at 60°C for a period of 3 h. The solution was cooled to 25°C, 100 mL DMF was
added, and then 5% (w/v) chain extender in DMF was added dropwise to the reaction
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mixture and stirred for 18 h. After the reaction was finished, the polymer solution was
precipitated in distilled water, and dried in a vacuum oven at 60 oC for at least 48 h
before further use and characterization.

Chemical Structure of Two Types of Biodegradable PUs

The chemical structures of the two types of biodegradable PUs are shown in
Figure 1. Samples are designated with the first letter indicating the hard-segment type (M
= MDI), second letter indicating the soft-segment (P = PCL), the number indicating the
soft-segment molecular weight, and the final letter indicating the chain-extender (B = BD
and M = MIDE). Thus, MP530B indicates the 1:1 copolymer of MDI, PCL with
molecular weight 530, and BD as the chain extender, and MP530M symbolizes MIDE as
the chain extender as shown in Figure 1.

Figure 1. Chemical structure of two types of degradable PUs. A: PU with BD as chain
extender. B: PU with MIDE as chain extender.
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Preparation of PU Thick Films

Polymer films were prepared by solvent casting. The synthesized PUs were
dissolved in tetrahydrofuran (THF) at a concentration of 4% (w/v). Polymer solution (12
mL) was then poured into leveled 5 cm PTFE casting plates and cast into thick films at
room temperature. Casting plates were covered to prevent dust from contaminating the
films and excessive fast casting, which may induce bubbles and result in surface defects.
The cast films were removed from the casting plates and dried in a vacuum oven at 60°C
for 4 h to remove residual solvent. The average thickness of the film was about 0.08-0.12
mm. Each film was then cut into 5 *12 mm2 rectangular strips for mechanical and
degradation tests. Each strip was about 10 mg. For all the experiments PLA (Mw = 139
kDa, Birmingham Polymers, Pelham, AL) was used as the control.

Thermal Behavior Characterization

PU samples were dried under vacuum at room temperature prior to being sealed
in an aluminum pan. Thermal analysis was performed in Mettler Differential Scanning
Calorimetry (DSC) analyzer (DSC 822e), with a heating rate of 20°C /min under constant
nitrogen flow. Polymer samples were heated to 70°C for 10 min, cooled to -100°C,
maintained at this temperature for 10 min, and then tested over the range from -100 to
150°C.

Hydrophilicity Test

Hydrophilicity of the materials was examined by measuring the contact angle, the
thickness change, and the weight change/swelling rate of the polymer films (n = 6 for
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each type of measurement of each material). Water contact angles were measured using a
home-made microscopy based contact angle analyzer. The wettability was examined by
immersing the polymer films in aqueous solution. The thicknesses of the films were
measured before and after being immersed in 0.1M phosphate buffered saline (PBS) for
24 h at 37°C. The film weight was measured before and after immersion in deionized
water for 24 h at room temperature, and the film-swelling rate was calculated.

Mechanical Property Testing

Tensile tests were performed at a crosshead speed of 10 mm/min using an MTS
858 Mini Bionix tensile tester. The materials will be used in water-rich environments,
such as culture media and live tissue. Therefore, the mechanical properties of the samples
were tested in both dry and wet conditions. Wet samples were prepared by saturating
them in 0.1M PBS for 12 h before testing. Six samples of each condition were measured
to get an average tensile strength and elongation.

Cytocompatibility Testing

Polymer samples were spin-coated on 18 mm diameter coverglasses (n = 6 for
each time point and each material). After being dried at room temperature in a vacuum
oven for 48 h, samples were sterilized in 75% ethanol for 15 min, washed with sterile
0.1M PBS five times, then put into 12-well tissue culture plates. Two types of assay were
carried out. A proliferation assay was used to examine the effect of the materials on cell
adhesion and proliferation, and a cytotoxicity assay was used to examine the dead/live
cell ratio after exposure to the materials. NIH 3T3 Fibroblasts (CRL-1658, ATCC,
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Manassas, VA) were used as a model cell type. Cells (1.6*104) were seeded on each
sample. Five hours later, when cells were attached on the polymer surfaces, samples were
rinsed once and transferred into new 12-well tissue culture plates to continue culture in
DMEM/F-12 with 10% FBS. Cell proliferation and viability on the samples were
examined at 1, 3, 5, and 7 days using proliferation and cytotoxicity assays. Briefly, a
stable cytosolic lactate dehydrogenase (LDH) released from dead cells (cytotoxicity
assay) or lysed cells (proliferation assay) was coupled to a tetrazolium salt
(2-p-iodophenyl-3-p-nitrophenyl-5-phenyl tetrazolium chloride, INT) and resulted in the
conversion of INT into a red formazan product. The concentration of red formazan
product was obtained by measuring the absorbance at 490 nm. The amount of color
present was proportional to the number of dead or lysed cells. PLA coated slides were
used as negative controls and latex was used as a positive control to verify the
effectiveness of the assay. Cell morphology for each sample was imaged at all the time
points before performing the two assays.

In Vitro Degradation

In vitro degradation of the polymer was evaluated by recording weight loss,
molecular weight changes, thermal behavior changes, and mechanical property changes
over time under static culture conditions in 0.1M PBS at 37°C. Each polymer strip was
placed in a small vial filled with 650 L 0.1M PBS (pH = 7.4) to perform the degradation
test. Strips of PLA were used as controls. The sealed vials were placed in the water bath
at 77°C. A higher temperature was used to accelerate the degradation rate. A
well-established relationship with different temperatures is available to convert the
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degradation profile to 37°C.[34] At each time point, six vials of each type of material
were sampled, rinsed five times with distilled water, and vacuum-dried for 24 h before
weight loss, thermal behavior, and molecular weight loss were analyzed. Changes in the
weight average molecular weight and its distribution over time were determined by gel
permeation chromatography (GPC; Thermal Electron, San Jose, CA). The GPC data were
calibrated with polystyrene standards (EasiCal PS-1, PolymerLabs, Amherst, MA) with
molecular weights in a range of 580-7,500,000 Da. DMF was used as an eluting solvent.
The polymers were dissolved at 0.25% (w/v) in the GPC carrier solvent (pure DMF) and
20 L samples were injected. Changes in the thermal properties upon degradation were
monitored using a Mettler DSC analyzer (DSC 822e). DSC traces of PU before and after
degradation were plotted and the glass transition temperatures (Tg) were determined and
compared.

Results and Discussion

Thermal Analysis

In the development of polymers for biomedical applications, it is important to
know their thermal behaviors, which determine the physical properties of the materials.
For example, if the value of the glass transition temperature (Tg) of the polymer is above
that of body temperature, the polymer is rigid. In contrast, if the Tg values are below
body temperature, as in the PUs used in this study, this indicates the elastomeric nature of
the materials.
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Figure 2 shows the DSC thermograms of the two types of PU samples. For PU
samples with 530 g/mol PCL-diol, Tgs of 17 and 20°C for MP530B and MP530M,
respectively, were observed. These were substantially higher than that of pure PCL (a Tg
of -58°C was detected). The Tg values of PCL-based PU indicated a certain degree of
hard and soft segment mixing. [37, 38] The slightly higher Tg of MP530M (20°C) than
that of MP530B (17°C) indicates that MP530M had less phase separation between hard
and soft segments than MP530B. [37, 38] The thermal behavior differences between
MP530M and MP530B may have been caused by some of the extra tertiary nitrogen
groups in chain extender MIDE. These extra nitrogen groups are able to form hydrogen
bonds with the oxygen atoms of the ester linkage and therefore decrease the phase
separation between hard and soft segments, which is consistent with the assumption that
some hard segments are dissolved in the soft segment matrix phase of PU. [39, 40]

Figure 2. DSC thermograms of MP530B and MP530M. The curve on the top shows the
thermal behavior of MP530B with Tg at 17°C and Tm at 112°C. The curve on the bottom
shows the thermal behavior of MP530M with Tg at 20°C and no obvious Tm is observed.
27

Heat capacity (Cp), the amount of heat required to change the temperature of a
material by one degree, is obtained by dividing the heat supplied by the temperature
increase during the DSC measurement. In particular, the changes in the heat capacity of
the two PU samples at the glass transition are 0.505 J/(kg K) for MP530B and 0.553 J/(kg
K) for MP530M. The changes in the heat capacity at the glass transition are related to the
mobility of the polymers in the rubbery state. The increase in Cp for MP530M over
MP530B is attributed to the weakened hard-segment domain cohesion induced by the
flexibility of the bonds connected to the tertiary nitrogen atom of the chain extender
MIDE. Weakened hard-segment cohesion decreases the effectiveness of the
hard-segment domain as a physical crosslinkage, thereby, increasing the mobility of the
soft-segment phase and the Cp. Therefore, MP530M has stronger chain mobility than
MP530B.

An endothermal peak, demonstrating the melting point (Tm), was observed for
MP530B at around 110°C as shown in Figure 2. The melting peak is associated with
long-range order in the hard segments. However, no endothermal peak at high
temperature was observed for MP530M. The lack of the endothermal peak in MP530M
indicates that hard segment ordering in MP530M is much less than that in MP530B.[41]
The lack of the melting endothermal peak of MP530M may have been caused by the
tertiary nitrogen atom and the pendant side methyl group in the chain extender MIDE
backbone. Bonds connected to the nitrogen atom are more easily rotated than those
connected to the carbon atom, a property attributed to the increased mixing of the side
methyl groups with the soft segments, thus decreasing microphase separation of hard and
soft segments.
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Based on the thermal behaviors of these two degradable PU materials, both
materials possess elastomer characteristics at body temperature. Because of the decreased
microphase separation in MP530M, one can expect improved hydrophilicity and,
therefore, faster degradation rate. In addition, the elasticity of the material may be
improved as well, due to the homogenous mixture of soft and hard segments for PU
synthesized using MIDE as the chain extender. These hypotheses were further
demonstrated using hydrophilicity, degradation, and mechanical tests.

Hydrophilicity Analysis

Both MP530B and MP530M swell in water. The amount of water absorbed into
the materials was examined by measuring the contact angle, the thickness change of the
samples, and the weight change/swelling rate of the polymer films. The amount of water
absorption is highly dependent on the material's composition and surface properties.
Contact angle is dependent on polymer surface hydrophilicity, while swelling behavior
reflects the bulk hydrophilicity of the polymer. Lower contact angle or higher swelling
ratio indicates higher hydrophilicity.

As shown in Table I, compared with MP530B, MP530M has a lower contact
angle (p > 0.05), greater thickness change (p < 0.05) in PBS, and greater weight change
(p < 0.05) in distilled water. These differences can be explained by the structure of
different chain extenders and the conformation of the polymer chains. Compared to BD,
MIDE has an extra tertiary nitrogen, which increases the relative amount of polar
segment, thus the hydrogen bonds between water molecules are easily formed. Moreover,
the side methyl group on MIDE increases the distance between the polymer chains, thus
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resulting in higher chain extensibility and lower phase-separation in MIDE-based PUs.
The opportunities and spaces for the penetration of water molecules increased
accordingly. Therefore, MP530M has higher hydrophilicity than MP530B.

Table I. Properties of Two Types of Biodegradable Polyurethanes Synthesized From
MDI, PCL530, and Chain Extenders of Either BD Or MIDE

Several nondegradable PUs are commercially used as wound dressing materials
because of their ideal mechanical and hydrophilic properties.[26] It is anticipated that the
MIDE chain extender-based degradable PUs could be used for wound dressing purposes
as well. One of the major requirements of a wound dressing scaffold is that it have a
certain hydrophilicity to maintain an intermediate level of fluid retention, preventing
massive liquid loss from the wound site. Thus, MP530M may have great potential to be
produced into wound dressing scaffolds; work is in progress to test the material in animal
skin wound models.

Mechanical Testing

The tensile testing results for the BD-based and MIDE-based PUs are shown in
Table I and Figure 3. Because of the low microphase separation of hard and soft
segments in MIDE-based PU, MP530M possesses a much wider elastic region (with
500% of elongation) compared to that of MP530B (less than 60% in elongation). This
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high elasticity of MP530M is important for engineering tissues with high elasticity, such
as muscle, tendon, ligament, heart, and blood vessels. In addition, because these two
types of polymers have a similar structure and chain extender content, similar elongation
at the break point was found for both types of PUs [Figure 3(B)]. However, lower
microphase separation resulted in a lower ultimate tensile strength (UTS) (p < 0.05) for
MP530M than for MP530B because the amount of semicrystallized hard segment
governs the UTS value. Although the tensile strength of MP530M is lower than that of
MP530B, the strength is sufficient for tissue engineering applications. [42] The
elongation ratio at break of two different materials were shown no significant difference
(p > 0.05).
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Figure 3. Mechanical properties of two types of PU. A: Typical stress-strain curves of
MP530B and MP530M. * symbols show the yield points of two PUs. MP530M has much
wider elastic region than that of MP530B, which may result from the homogenous
mixture of hard and soft segments in MP530M as discussed in Thermal Analysis section.
B: Elongation at break of MP530B and MP530M in dry or PBS saturated conditions are
shown. In dry condition, there is no significant difference between two materials.
However, in PBS saturated wet condition, MP530M has significantly higher elongation at
break than MP530B (p < 0.05). The elongation at break for both materials is higher in
wet condition than in dry condition (p < 0.05). C: UTS of MP530B and MP530M in dry
and PBS saturated wet conditions. There is no significant UTS change between dry and
wet conditions for MP530B. However, the UTS decrease significantly for MP530M in
wet condition, which indicates the difference in hydrophilicity for two materials.
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As also shown in Figure 3 (B, C), the type of chain extender affects the strength
of PUs in both dry and wet states. There is no significant difference in tensile strength (p
> 0.05, Table I) for MP530B in either dry or wet state. However, MP530B elongates
more when wet (p < 0.05, Table I). In contrast, MP530M is very sensitive to water, and
the tensile strength decreases significantly when exposed to water (p < 0.05, Table I).
Two factors would be responsible for this effect on MP530M. One is the higher
hydrophilicity of MIDE-based PU, which appears to have greater influence on the
mechanical properties of MIDE-based PUs than those of BD-based PUs in the wet state.
The other factor is the extra tertiary nitrogen groups in MIDE-based PUs, which have the
ability to form extra hydrogen bonds with environmental water molecules. Moreover, the
side methyl groups on MIDE increase the distance between polymer chains, thus
increasing the flexibility of the polymer chain. Both factors may facilitate the penetration
of water molecules into the polymer matrix, resulting in a decrease in the stress strength
of the MIDE-based PU through the interruption of physical crosslinkages among polymer
chains. Likewise, the elongation ratio of MIDE-based PU in the wet state is higher than
that of BD-based PUs.
Cytocompatibility Testing

Both qualitative and quantitative evaluations were carried out to compare the
cytocompatibility and cytophilicity of two PUs. The morphology of the NIH 3T3
fibroblasts grown on two PU materials and PLA and latex controls were monitored using
an inverted light microscope equipped with a CCD camera. As shown in Figure 4,
fibroblasts adhere and proliferate well on PLA, MP530B, and MP530M. Cells spread on
the surface with a normal flattened appearance, indicating that MP530B and MP530M
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have good cytocompatibility. Fibroblasts on MP530M reached confluence faster than
MP530B and PLA, indicating improved cytophilicity with MP530M. To further confirm
the qualitative observations, two quantitative assays were carried out: a proliferation
assay to examine the effect of materials on the cell adhesion and proliferation, and a
cytotoxicity assay to examine the dead/live cell ratio after exposure to the materials. As
shown in Figure 5 (A), the total number of cells on the MP530M, MP530B, and PLA
increased with the time in culture. However, the total number of cells on latex did not
increase significantly, indicating that latex caused problems with DNA synthesis and
therefore slowed proliferation. Figure 5(B) shows the percentage of dead cells in the
culture at different time points. The lack of significant differences in the percentage of
dead cells among MP530M, MP530B, and PLA groups indicates good cytocompatibility
of MP530B and MP530M materials. In contrast, an increase in cell death was apparent
after day 1 time point in the well with latex. The density of the cell nuclei was greatly
decreased as shown in Figure 4, which indicated DNA damage of the cells. Cell
proliferation was also greatly decreased after day 1. The data obtained from the latex
group demonstrated that both the qualitative assay and quantitative assays work well in
this study.
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Figure 4. Light microscope images of NIH 3T3 fibroblasts grown on four types of
materials for four different time points. Fibroblasts grew and spread well in monolayer on
PLA, MP530B, and MP530M at all the time points, demonstrating good
cytocompatibility of these materials. However, fibroblasts growing on positive latex
control showed abnormal morphology, which indicates the cytotoxicity of latex. Scale
bar = 100 um.
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Figure 5. Quantitative assays on the proliferation and cytotoxicity of NIH 3T3 fibroblasts
on MP530B, MP530M, PLA control, and latex control. A: Proliferation assay. B:
Cytotoxicity assay.
The proliferation of fibroblasts on different materials was affected by
cell-material interactions. There was no significant difference in proliferation of
fibroblasts cultured on PLA controls and the two types of PUs from day 1 to day 3.
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However, at day 5 cells divided faster on MP530M than on those on MP530B and PLA
control. This may be explained by the higher surface hydrophilicity of MP530M. This
observation is in agreement with the observations of other groups of cell-polymer
interactions where cell attachment increased with increasing material hydrophilicity.[43]
In addition, it has been found that cells prefer to proliferate on the surface of polymers
with slightly positively charged surfaces.[43] In MP530M, tertiary nitrogen atoms in
MIDE give a relatively higher polarity than BD, which helps cell proliferation. Higher
hydrophilicity and polarity of MP530M are responsible for faster cell proliferation.
Although very high hydrophilicity may not promote cell growth, in a certain range
(moderate hydrophilicity), with the increase of hydrophilicity, the cells attach and
proliferate better.[43]
In Vitro Degradation
Degradation of a material means that the molecular weight, mass, and mechanical
properties decay over time. Therefore, the degradation behaviors of MP530B and
MP530M were examined by changes in molecular weight, thermal behavior, pH, weight,
and mechanical behavior. For both MP530B and MP530M, molecular weight varied only
a small amount during the first 2 days in culture at 77°C [Figure 6 (A)]. Molecular weight
of MP530M dropped significantly on day 3. However, MP530B degraded significantly
slower with the molecular weight remaining constant till day 7. After 7 days in 0.1M PBS
culture at 77°C, MP530M lost about 20% of initial molar mass, while MP530B lost only
2%; 20 days later, MP530M lost about 58% of initial molar mass while MP530B lost
16%. Thus, MP530M has a 4-10 times faster degradation rate than MP530B. GPC data
clearly demonstrated that MIDE-based PU has a faster degradation rate than BD-based
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PU. PCL and most PCL-based polymers, such as PCL-based PU, degrade slowly,
because of the high hydrophobicity of PCL, and therefore, are resistant to hydrolysis.
This study has demonstrated that the introduction of MIDE increases the hydrophilicity
and degradation rate when compared with BD-based PU. Comparing the chemical
structure of the two chain extenders, MIDE contains extra tertiary nitrogen atoms
whereas BD has no extra nitrogen. As described above, the side methyl groups in the
MIDE backbone not only easily form hydrogen bonds with water, but also increase the
distance between each polymer chain producing more amorphous regions. Both factors
may result in the much faster degradation rate of MIDE based PU.
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Figure 6. Degradation behavior of MP530B and MP530M in 0.1M PBS at 77°C. A: The
average retained molecular weights of MP530B and MP530M change as a function of
culture time. B: The glass transition temperatures change as a function of culture time. C:
pH values of 0.1M PBS media where polymer degrade in change as a function of time.
PLA samples were used as control. D: Mechanical properties of MP530B and MP530M
change as a function of time.
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For biomedical use, it is important to obtain the correlation between the
degradation profile at 37 and 77°C. It was reported [34] that the degradation rate of
MP530B at 37°C is about 1/20 of the degradation rate at 77°C. Thus, the degradation of
MP530M at 37°C can be postulated from the degradation profile at 77°C. MP530M may
lose 50% of its initial molecular weight after about 9-10 months at 37°C, while MP530B
may degrade 3-4 times slower than MP530M. To further increase the degradation rate of
elastic PU, hard segments or soft segments with more hydrophilic nature can be
employed. Our lab has synthesized elastic degradable PU with half-life degradation
ranging from 2 months to several years. Therefore, degradable PUs, some of the most
promising materials for tissue engineering applications, with different degradation
profiles can be developed and applied for engineering different types of tissues.
Figure 6(B) shows Tg changes during MP530B and MP530M degradation
processes. There was an increase in Tg during the first 2 days, which may have been
caused by the annealing effect when samples were initially put into 77°C. As the
hydrolysis procedure was initiated, Tg decreased with the degradation time because
molecular weight decreased during the degradation process. During degradation, the
physical crosslinkages were destroyed, the percentage of short chains increased, and the
phase separation increased, which resulted in the enhanced mobility of polymer chains.
Thus the Tg decreased correspondingly.
As previously reported, polylactide- and polyglycolide-based degradable
polymers may produce an acidic environment during degradation.[44-46] Degradation
products of MP530M and MP530B are carboxylate and hydroxyl groups, which may
produce an acidic environment. To examine whether MP530B and MP530M influence
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the pH of culture media, pH values were recorded during polymer degradation at 77°C.
The changes in pH of PBS culture media with culture time are illustrated in Figure 6(C).
PLA was used as a control. Both MP530B and MP530M have little effect on pH of the
culture media. For example, MP530M, with a faster degradation rate than MP530B,
caused the pH to decrease no more than 0.25 points after 32 days of degradation at 77°C,
which is equal to 9-10 months of degradation at 37°C. In contrast, the pH values of PLA
cultured media markedly decreased in the first 10 days [Figure 6(C)]. Therefore, the
degradation products of MP530B and MP530M do not significantly cause the pH value
change in the culture media in vitro.
The changes in UTS of MP530B and MP530M as a function of in vitro
degradation time are shown in Figure 6(D). Although MP530M has a lower tensile
strength than MP530B, they both have a similar slope of tensile strength loss during the
degradation. The tensile strengths of MP530B and MP530M were examined at both dry
and PBS saturated wet conditions as shown in Figure 7. As shown in Figure 3(C), the
influence of water on the tensile strength of MP530M is far stronger than on MP530B
before degradation process. The wet MP530M sample had only 30% of the tensile
strength of the dry sample. The influence of water on the tensile strength of MP530B is
much lower, which is caused by the higher hydrophilicity of MP530M than MP530B.
Therefore, it is easier for water molecules to attack the bonds of the MP530M, which
undermines the physical interaction among polymer chains. This results in lower tensile
strength of the wet samples when compared to the wet MP530B samples. However,
during the degradation, hydrophilic groups in MP530M were released, and therefore the
influence of the water on MP530M became weaker. As shown in Figure 7(A), the
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differences between the dry and wet MP530M samples in UTS value became less and
less during the degradation process.

Figure 7. UTS of MP530M (A) and MP530B (B) as a function of hydrolysis time in 0.1M
PBS at 77°C. Curves with solid symbols were tested under dry condition, and curves with
hollow symbols were tested under PBS-saturated condition.
Conclusions
This study aimed at developing degradable PU with adjustable mechanical
properties, degradation behaviors, and biocompatibility. The hypothesis is that the
mechanical properties, degradation profile, and cytophilicity of the degradable PU can be
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adjusted using a chain extender with more polarized, hydrophilic, and flexible
characteristics. MDI and PCL based PUs were investigated as a model degradable PU
system. BD and MIDE were studied as two model chain extenders. In vitro degradation
studies showed that PU containing MIDE possesses a higher degradation rate than PU
synthesized using BD as a chain extender. Mechanical testing of dry and wet samples
demonstrated that PU containing MIDE has a much higher elongation in the elastic
region than PU containing BD. PU containing MIDE is more hydrophilic and retains
more liquid during the in vitro culture. Furthermore, preliminary cytocompatibility
studies showed that both types of degradable PU are nontoxic, and fibroblasts adhere
better and proliferate faster on MIDE containing PU than BD containing PU. In
conclusion, by changing the types of chain extender used during degradable PU
synthesis, the degradation rate, mechanical properties, hydrophilicity and cytophilicity
can be adjusted for different tissue engineering applications.
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PART II: CHAPTER 5
SYNTHESIS AND CHARACTERIZATION OF BIOCOMPATIBLE, DEGRADABLE,
LIGHT-CURABLE, POLYURETHANE-BASED ELASTIC HYDROGELS
Abstract
A series of degradable polyurethane based light-curable elastic hydrogels were
synthesized from polycaprolactone diol (PCL-diol), polyethylene glycol (PEG), lysine
diisocyanate (LDI), and 2-hydroxyethyl methacrylate (HEMA) through UV light initiated
polymerization reaction. LDI was used as hard segment and PCL and/or PEG were used
as soft segments. By changing the PCL to PEG ratio during the pre-polymer synthesis,
polyurethanes with different soft segmental structures, hydrophilicity, and cytophilicity
were obtained after light-initiated polymerization. The chemical structures of the
synthesized polymers were characterized using differential scanning calorimetry (DSC),
thermogravimetric analysis (TGA) and Fourier transform infrared spectroscopy (FTIR).
Physical properties such as swelling, mechanical properties, and in vitro degradation
were evaluated. Materials containing a higher ratio of PEG exhibit higher water
absorbance, higher degradation rate in vitro, and lower mechanical strength in the
hydrated state. Mouse embryonal carcinoma-derived clonal chondrocytes were used as a
model cell type to study the cytocompatibility of the synthesized polymers. Chondrocyte
attachment, proliferation rates, and morphologies all varied with changes in the PCL/PEG
ratio. With a higher PEG ratio, lower cell attachment and proliferation were observed. To
improve the cell attachment and proliferation on high PEG content hydrogels, bioactive
molecules, such as peptides and proteins, were conjugated or immobilized in the gel
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matrix during the light-curing process. In this study, a short peptide, Arg-Gly-Asp-Ser
(RGDS), was used as a model biomolecule and incorporated into the gels during the
light-curing process and improved cell growth was observed. In summary, the use of
PCL/PEG at different ratios, as well as the introduction of HEMA into polyurethane,
allows the synthesis of a series of biocompatible elastic hydrogels with tunable physical
and cytophilic properties through light initiated polymerization. This series of materials
also allows for controlling cell attachment and growth by incorporating bioactive
molecules during the light-curing process.
Introduction
A material that is to be used for tissue repair requires a wide range of physical and
biological properties including biocompatibility, biodegradability, strength, and elasticity.
[1] Due to their excellent biocompatibility, chemical versatility and superior mechanical
properties, polyurethanes have been extensively investigated for biomedical applications,
including cardiovascular devices such as vascular prostheses, intra-aortic balloons,
cardiac valves and insulating sheaths for pacemakers, membranes for dialysis,
craniofacial reconstruction, breast implants, etc. [2-8] Most polyurethane materials
utilized for these applications are nondegradable.
In recent years, interest in using resorbable or degradable polyurethanes for tissue
regeneration has been continuously increasing. Several series of degradable
polyurethanes have been developed for applications including cardiovascular repair,
ligament reconstruction, cancellous bone regeneration, and controlled drug delivery,
among others. [9-11] Most degradable polyurethanes were developed by the introduction
of labile moieties, such as caprolactone, [12] lactides, [13] hydroxybutyric acid, [14],
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saccharide [15], or amino acids [16], as either soft segments or chain extenders. The
labile bonds can be broken in vivo either enzymatically or chemically, in most cases by
hydrolysis. In some studies, polyethylene glycol (PEG) was introduced into the soft
segment to adjust the susceptibility of the polymer chains to hydrolysis [17].
Since polycaprolactone (PCL) and its degradation products are nontoxic and it has
been approved by the Food and Drug Administration (FDA) and evaluated for many
tissue repair and drug delivery applications, polycaprolactone diol (PCL-diol) is one of
the most frequently used building blocks for soft segments of degradable polyurethanes.
[9,17-20] However, its hydrophobicity and semi-crystalline structure determine its very
slow degradation profile. [9] In those studies, [9, 17-20] polyurethanes with a PCL
segment exhibited improved elasticity, tensile strength and yield strength when compared
to PLC due to the formation of hydrogen bonds among polyurethane chains.
Due to its chemical functionality, super flexible hydrophilic chain motion,
non-toxicity and non-immunogenicity, [21-22], PEG is another candidate for the soft
segment of polyurethanes. PEG is widely used for tissue engineering, drug delivery,
surface modification of implants, etc. [21, 23-27]. For instance, because its hydrophilic
surface has a low interfacial free energy in contact with body fluids, PEG has been used
for surface modification of a blood contacting construct to decrease protein adsorption
and platelet adhesion for cardiovascular application. [28] PEG has been functionalized
with dimethacrylate groups and crosslinked to form hydrogels via light-initiated
polymerization and tested for cartilage tissue repair. [21] PEG can be incorporated into
the polyurethane structure to form hydrogel materials that inhibit protein adsorption and
cell adhesion by dramatically increasing the hydrophilicity of the materials. Reduced
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protein or cell adhesion allow to limit unwanted protein and cell adhesion and therefore
provide great opportunities for functionalizing these materials with specific biomolecules
to promote the attachment of desirable cell types, and the same time, wards-off unwanted
cell types.
Hydrogels, an insoluble network of polymer chains that swell in aqueous solution,
are a class of materials that have shown great promise for tissue repair due to their
tissue-like water content, permeability, adjustable functionality, and low coefficient of
friction. [29]. Many types of tissues in the body are in the form of hydrogels. Native
cartilage, for instance, is a durable elastic tissue, with an extracellular matrix consisting
mostly of proteoglycans and type II collagen. The extracellular matrix of cartilage is
hydrogel in nature [30] and cartilage is able to withstand large loads by virtue of the
matrix’s strength and the exudable water held within the tissue. Thus, hydrogels are
especially attractive for cartilage tissue regeneration due to their excellent diffusive
permeability, minimal irritation to surrounding tissues, low surface friction and wear that
related to the strong water retention of the hydrophilic network. [31]. However, most
biocompatible degradable hydrogels developed to date are not strong enough or elastic
enough for immediate physiological loading in cartilage repair.
To overcome the disadvantages associated with currently available soft hydrogels,
we are endeavoring to develop a highly elastic biocompatible and degradable hydrogel
for cartilage repair. Since most cartilage defects are irregular in shape and size, instant
polymerization causing the gel to assume the shape of the defect offers a great advantage
for customizing the scaffolds or even for computer-aided scaffold fabrication with precise
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temporal and spatial control. [32, 33]. To this end, a series of photopolymerizing elastic
hydrogels were developed and characterized in this study.
Materials and Methods
Materials
Lysine diisocyanate (LDI) was obtained from Kyowa Hakko Koygo Co., Ltd,
Tokyo, Japan. Stannous octoate (Sn(oct)2, Sn[CH3(CH2)3CH(C2H5)COO]2) and
polycaprolactone diol (PCL-diol) with Mn =530 (PCL530) were purchased from
Sigma-Aldrich Inc. (St. Louis, MO, USA). 2-hydroxyethyl methacrylate (HEMA),
dimethyl sulfoxide (DMSO), and polyethylene glycol (PEG600) with average molecular
weight 600 (Mw=600) were purchased from Fisher Scientific International. UV
light-initiator Irgacure 2959 was kindly provided by Ciba Specialty Chemicals, Inc. LDI
was purified by vacuum distillation, while DMSO was distilled with calcium hydrogen
(CaH2) at atmospheric pressure under nitrogen protection. PCL530 and PEG600 were
dehydrated in a vacuum oven at 60 °C for 48 hours, then 4 Å molecular sieve was added
to maintain dryness at room temperature. Sn(oct) 2 and HEMA were dried by 4 Å
molecular sieve with stirring at room temperature overnight to eliminate the trace water.
Irgacure 2959 was used without further purification.
UV light generator (American Ultraviolet Company, Santa Ana, CA, USA) was
used to generate the UV light used to initiate polymerization. The light intensity used was
800mW/cm2 at a wavelength of 365 nm. Irradiation from the generator was transmitted
through a quartz optical guide fiber (diameter: 5mm; length: 1m) to the pre-polymers.
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Synthesis of LDI based biodegradable hydrogel
Pre-polymers of UV light curable polyurethanes with different PCL-PEG molar
ratios were synthesized using a traditional two-step method 2. Briefly, the stoichiometry
of the synthesis reaction was approximately 2:1:1 of hard segment (LDI):soft segment
(PCL530, PEG600, or their mixture):chain terminator (HEMA). Three different PCL530
to PEG600 ratios were studied as model materials, i.e., 100% PCL530, a mixture of equal
parts PCL530 and PEG600, and 100% PEG600. LDI was dissolved in DMSO at room
temperature. A calculated amount of PCL530-PEG600 mixture was added dropwise into
the LDI solution with vigorous stirring, then 0.1% wt Sn(oct)2 was added as catalyst. The
mixture was allowed to react at 80 °C for 3 hours under nitrogen protection. The resulting
mixture was cooled to room temperature, and a calculated amount of HEMA with 0.1
wt% 4-methoxyphenol (MEHQ, inhibitor) was added to the reaction mixture and stirred
for another 24 hours in the dark under dry oxygen atmosphere protection to prevent the
self-crosslinking reaction. The final pre-polymers were viscous liquids and can be
preserved in the dark at 4 °C. The pre-polymer was degassed using nitrogen to remove
the oxygen before final UV light polymerization, then 0.04 wt% UV light initiator
Irgacure 2959 was added and mixed homogeneously. This viscous mixture was poured
into Teflon molds and exposed to UV light for 20 seconds to obtain either elastic rod or
film samples. Samples were then rinsed in 75% ethanol solution for 24 hours and vacuum
dried for use in future experiments. The resulting specimens were clear elastomers. The
polymerization reaction procedure and chemical structures of the final product are
illustrated in Figure 1.
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Figure 1: Schematic diagram shows the preparation of LDI, PEG600, PCL530 and
HEMA based light curable degradable hydrogels. The PCL530:PEG600 ratio was
adjusted for synthesizing materials with different hydrophilicity.
For the model hydrogels with bioactive peptides, RGDS (American Peptide
Company Inc., Sunnyvale, CA, USA) at a final concentration of 2 µmol/ml was
crosslinked into the hydrogel during the UV light-initiated polymerization.
Chemical structures of two types of biodegradable polyurethanes
Samples were designated with the first letter indicating the hard-segment type (L=
LDI), the second to the fourth letters indicating the polycaprolactone with 530 molecular
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weight (PCL530) in the soft segment (PCL=PCL530), the number following the fourth
letter indicating the molar percentage of PCL530 in the soft segment, and the final letter
indicating the chain terminator (E= HEMA). For instance, LPCL50E indicates the
polymer with LDI as hard segment, mixture of 50:50 molar ratio of PCL530 and PEG600
as soft segment, and HEMA as chain terminator. LPCL0E symbolizes that soft segment
of polyurethane is 100% PEG600 and LPCL100E symbolizes that the soft segment of
polyurethane contains 100% PCL530.
Sample Preparation
The solid cylindrical samples for mechanical testing were UV light polymerized
in a Teflon cylindrical mold with inner diameter

and height 10 mm; film samples for

other characterizations and evaluations were UV light polymerized in a Teflon Petri dish
with thickness between 0.6 mm before hydration.
Thermal Behavior Characterization
Characterization of the thermal behavior of the polymers was performed with a
Mettler Differential Scanning Calorimetry (DSC) analyzer (DSC 822e), with a heating
rate of 20 °C/min under constant nitrogen flow. Samples were heated to 70 °C for 10
minutes, cooled to -100 °C, maintained at this temperature for 10 minutes, and then tested
over a range from -100 °C to 150 °C. Prior to being sealed into an aluminum pan, samples
were dried under vacuum at room temperature for 24 hours.
Thermogravimetrical analysis (TGA) under nitrogen atmosphere was carried out
on a Mettler TGA analyzer (SDTA851e), with a heating rate of 10 °C/min. Samples were
heated from room temperature to 800 °C. The mass of sample used was approximately 10
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mg to avoid significant temperature gradients. Prior to being tested, samples were dried
under vacuum at room temperature for more than 24 hours.
Examination of Chemical Composition
Attenuated total internal reflective-Fourier transform infrared spectroscopy
(ATR-FTIR, Research series 100, Madison Instrument, Inc., Madison, WI, USA) was
used to characterize the chemical composition of synthesized polymers. Polymer films
were dehydrated in a vacuum oven at 60 °C for 36 hours and then placed on the sample
holder in the nitrogen protected chamber for FTIR characterization at room temperature.
Swelling Test
Swelling property of the materials was measured by weight change of the sample
in the film form (4 mm × 4 mm × 0.6 mm) before and after soaking in double deionized
water for 12 hours at room temperature. Filter paper was used to remove the water on the
surface of samples before weight measurements. Six samples of each material were
measured. The weight swelling ratio is determined by the weight of the swollen sample
divided by the weight of the dry sample.
Mechanical Property Testing
Samples used for mechanical testing were in solid cylinder form (10 mm height, 8
mm diameter before being hydrated) and were hydrated in 0.1 M PBS for 12 hours before
mechanical testing. Compressive mechanical tests were performed on an MTS Synergie
100 materials tester (MTS System Co., Eden Prairie, MN, USA) with a maximum load of
50 N and a 1 mm/second crosshead speed. The elastic modulus was calculated from the
initial slope of the linear stress-strain curve, and the yield strength was calculated at the
point of 10% compression rate. Five samples were analyzed for each material.
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Cytocompatibility Testing
Hydrated polyurethane films were cut into round pieces (16 mm in diameter) and
placed in 12-well plates (n=6 for each time point and each material). Samples were
sterilized with 75% ethanol solution for 30 min and then left in excess sterilized PBS
solution overnight and washed five times to replace the ethanol before cell seeding.
Mouse embryonal carcinoma-derived clonal chondrogenic ATDC5 cells were
used as a model cell line to study the compatibility of materials to cartilage cells.

Cells

were cultured in Dulbecco's modified Eagle's medium (DMEM)/Ham's F-12 medium
(Sigma) containing 5% fetal bovine serum (FBS, Invitrogen, Gaithersburg, MD), 10
ug/ml human transferrin (Sigma), 3×10-8 M sodium selenite (Sigma), and 50 units/ml
penicillin and 50 ug/ml streptomycin. For induction of chondrogenesis, human insulin
(Sigma) at 10 ug/ml was added to the culture. The cells were cultured at 37 °C in a
water-jacketed incubator with 5% CO2. At the time of the experiments, cells were
trypsinized and re-suspended at a concentration of 1.0 × 106 cells/ml; 1 µl cell suspension
(103 cells) was seeded on each polyurethane film and 1 ml culture media added. At each
time point, alamarBlue assay (Invitrogen, Gaithersburg, MD) was used to measure the
cell proliferation following the manufacturer recommended protocols. Briefly, cell
metabolic activity results in the chemical consumption of alamarBlue. The reduction of
the alamarBlue in culture media can be measured by the change of the indicator
combined with alamarBlue. At each time point, culture media was aspirated and 1 ml
culture media with 10% (v/v) alamarBlue was added to each well. After 3 hours in
culture, 100 µl media was transferred to 96-well UV transparent microplates (Costar) for
UV absorption measurement (n=6 for each material at each time point). The change in
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UV absorption reflected the metabolic activity of the living cells in a 3-hour period, thus
indirectly reflecting the amount of living cells in each well. Empty wells were used as
negative control. Cell morphology for each sample was imaged at 2 weeks of culture.
In-vitro Degradation
In vitro degradation of the polyurethane materials was evaluated by recording the
weight loss of samples over time in 0.1 M PBS at 37 °C.

Samples in membrane form

(8-10 mg) were placed in a small vial filled with 500 µL 0.1 M PBS (pH=7.4) to perform
the degradation test (n=6 for each material). Those vials were placed in a 37 °C water
bath with gentle shaking at 30 cycle/min to simulate dynamic in vivo tissue environment.
At each time point, six vials of each type of material were sampled, rinsed for two hours
with double deionized water, and vacuum-dried for 24 hours before weight loss was
analyzed. The PBS in each vial was also collected for measurement of pH.
Results
Thermal Analysis
In the development of polymers for biomedical applications, it is important to
know their thermal behaviors, which determine the physical properties of the materials.
For example, if the value of the glass transition temperature (Tg) of the polymer is above
that of body temperature, the polymer is rigid. In contrast, if the Tg values are below body
temperature, this indicates the elastomeric nature of the materials. Figure 2A shows the
DSC thermograms of the three model materials studied. All three materials displayed
glass transition temperatures below body temperature, suggesting that these
polyurethanes exhibited elastomeric natures at body temperature. Possesssing an
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elastomeric nature at body temperature is an important quality for polymers in soft tissue
engineering.
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Figure 2: Thermal behaviors of LPCL100E, LPCL50E and LPCL0E. (A). DSC
thermograms of three materials. The top curve shows the DSC curve of LPCL100E with
Tg at 15 °C and no Tc is observed. The middle curve shows the DSC curve of LPCL50E
with Tg at 3 °C and Tc at 178 °C. The bottom curve shows the DSC curve of LPCL0E
with Tg at -6 °C and Tc at 189 °C. (B). Thermogravimetric analysis (TGA) curves of
LPCL100E, LPCL50E, and LPCL0E with onset temperature at 246 °C, 259 °C, and 276
°C, respectively. Small insert shows the TGA curves at 240 °C to 300 °C.
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All three types of polyurethane have the same soft segment percentage (60 wt%)
and hard segment percentage (40 wt%); however, as the PCL530 content decreased in the
soft segment, lower Tg values were observed. For instance, Tg of LPCL100E is 15 °C,
while Tg of LPCL50E is 3 °C, and Tg of LPCL0E is –6 °C. Because Tg values indicate
the degree of hard and soft segment phase mixing, [34,35] the highest Tg (LPCL100E
=15 °C) among the three materials indicates that the polymer with 100% PCL530 in the
soft segment had the highest phase mixing. The Tg of LPCL0E (–6 °C) is 9 °C lower than
that of LPCL50E (3 °C), indicating that increasing the content of PEG600 in the soft
segment causes less phase separation among soft and hard segments in the polymer
matrix.
The Tg change caused by the change of PCL:PEG ratio in the soft segment can be
explained by the different chemical structure of PCL530 and PEG600. PCL530 with
extra ester groups containing pendant carbonyl groups (-C=O) exhibits higher
extra-molecular distance and molecular mobility when compared to PEG600. Moreover,
these carbonyl groups in the soft segment can form strong hydrogen bonds with urethane
groups in the hard segments. Therefore, the increased molecular mobility and the
hydrogen bonds caused higher phase mixing and higher Tg in PCL530 based
polyurethanes. On the other hand, in the materials containing PEG600, the linear main
chain in PEG containing the repetitive ether structure (–C-O-C-) has high rotation
flexibility, but low mobility of the whole polymer chain, and can be easily rotated and
arranged into an orderly structure. Therefore, the PEG600 region in the soft segment
exhibits the tendency to form orderly arrangement with lower chain mobility, which
causes the phase separation. The formation of the ordered region in soft segments can be
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indirectly observed in DSC thermogram, which shows the exothermic peaks (Tc) for
LPCL0E (189 °C) and LPCL50E (178 °C) (Figure 2A). Compared to LPCL0E, the
strength of the Tc peak of LPCL50E became weaker due to the decreased amount of
ordered area in the soft segment; and the disappearance of exothermic peak of
LPCL100E can be attributed to the highly disordered soft segment region and the higher
degree of phase mixing.
TGA curves of three materials are shown in Figure 2B. The onset temperatures of
thermal decomposition for LPCL100E, LPCL50E and LPCL0E are 246 °C, 259 °C and
276 °C, respectively. The onset temperatures decrease with the decrease of the PEG600
content in the soft segment, which reflects the increase of the thermal stability of the
materials. The increased thermal stability can be attributed to the orderly arranged soft
segment area and higher phase separation in polymers containing PEG600, which is
consistent with the DSC results showing that LPCL100E and LPCL50E possess
exothermic processes at higher temperatures.
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FTIR analysis
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Figure 3: FTIR spectra of three types of polyurethane with different ratios of PCL530 and
PEG600 in the soft segment. The region from 1780 to 1600 cm-1 indicates to the C=O
stretching absorption, the region from 1580 to 1300 cm-1 indicates to the –NH- with
hydrogen bonds and the region from 1310-1000 cm-1 indicates to –C-O-C- stretching
absorption.
Figure 3 shows the FTIR spectra of three types of polymers with different ratios
of PCL530 and PEG600 in the soft segment. All three polymers display the peaks of free
amide group (NH) stretching absorption at 3280–3252 cm-1, carbonyl group (C=O)
stretching absorption at 1780-1600 cm-1, hydrogen bonded NH stretch absorption at
1580-1330 cm-1, and ether group (–C-O-C-) stretching absorption at 1310-1000 cm-1 36.
Due to the overlap of the carbonyl group of LDI, HEMA and PCL, the carbonyl group
displays a broad stretching absorption at 1780 -1600 cm-1. In LPCL100E spectra, the
carbonyl stretch absorption exhibits weaker and broader peaks when compared to the
other two polymers because of the higher phase mixing of soft segment and hard
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segment. The molecular interaction (hydrogen bonds) of carbonyl groups and amide
groups causes the decreased strength of the carbonyl group’s absorption. This increase in
hard and soft segment mixing also results in the broad hydrogen bonded amide group’s
stretch absorption at 1580-1330 cm-1 in LPCL100E, which is consistent with the thermal
analysis results indicating that the material with higher content of PCL530 in the soft
segment exhibited higher phase mixing. The ether group stretch absorption at 1310-1000
cm-1 exhibits a different shape due to the different ratio of PCL and PEG in the soft
segment. Ether group absorptions from LDI, HEMA, PEG and PCL are overlapped in
this region. In LPCL0E spectra, ether group absorptions display sharp peaks with a small
shift to high wavelength. This may be due to the higher content of ether groups in soft
segments and the formation of the ordered phase separated structure, in which the soft
segment containing 100% PEG600 caused the formation of a linear structure that
enhanced absorption of the ether groups and shifted the peaks to higher wavelengths.
However, compared to the ether group absorptions in LPCL0E, the ether groups in
LPCL50E showed wider and weaker peaks. This can be explained by the decreased ether
group content in the soft segment due to the decreased PEG content in LPCL50E;
moreover, the enhanced molecular interaction between PCL and PEG segments
undermines the orderly structure and increases the hard-soft segment phase mixing,
which caused the wider ether group absorption peaks. However, compared to LPCL50E,
ether groups in LPCL100E showed relatively sharper absorption peaks and the shifts to
lower wavelength. This sharper absorption in LPCL100E may contribute to the 100%
percent of PCL in soft segments and there is no interaction with PEG600. The shifts to
lower wavelengths may be due to the higher phase mixing of hard and soft segments in
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LPCL100E. Compared to LPCL0E, due to the lower content of ether groups in
LPCL100E, the ether group absorption peaks in LPCL100E are relatively lower.
Therefore, FTIR curves of the three materials reflect the differences in the chemical
structure, such as soft segment content, phase separation, and the molecular interaction
inside the polymers.
Swelling Behavior
Swelling behaviors of three materials were measured by water retention at room
temperature. All three polymers absorb water; however, the water retention ratio differs
dramatically among the three materials. With the increase of the PEG content in the soft
segment from 0% to 100%, the water retention ratio increases from 3.2±1.4% to
66.0±2.5%. The reason PEG-free material possesses water retention property is that
carbonyl groups (C=O) exist in this hard segment. LDI and HEMA can form weak
hydrogen bonds with environmental water molecules, which causes hydrophilicity of the
material. However, hydrophilicity resulting from the hard segment is insignificant when
compared with the water retention ability from PEG600, which possesses repetitive ether
(–C-O-C-) groups on the linear chains and can form strong hydrogen bonds with water
molecules. In contrast, PCL exhibits very low hydrophilicity due to the existence of a
high percentage of water repellent carbonic bonds (-C-C). Therefore, changing the ratio
of PEG and PCL can adjust the ratio of water repellent and water absorbent groups in soft
segments, and based on this principle, the hydrophilicity of the elastic biodegradable
polyurethanes can be finely tuned accordingly for different biomedical applications. For
example, polymers used for gene delivery system are generally required to be highly
hydrophilic, [11, 37] polymers used for wound dressing material need moderate
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hydrophilicity, [38] while polymers applied as the scaffold for the anterior cruciate
ligament (ACL) reconstruction require low hydrophilicity. [9] Therefore, synthesis of
elastic polyurethanes with adjustable hydrophilicity would expand their utility as
candidate materials for a wide range of biomedical applications.
Mechanical Testing
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Figure 4: Mechanical properties of the hydrated samples. Solid samples were made 10
mm in height and 8 mm in diameter. Fifty Newton compression force was applied at 1
mm/second crosshead speed.
As shown in Figure 4, three polymers with different PCL: PEG600 ratios show
significant differences in mechanical properties under hydrated condition (P<0.05).
Figure 4 shows typical stress-strain curves of three polymers under compression. The
yield strengths (at 10% compression rate) of LPCL0E, LPCL50E, and LPCL100E are
0.24±0.03 MPa, 0.43±0.07 MPa, and 0.88±0.12 MPa, respectively. The elastic moduli of
LPCL0E, LPCL50E, and LPCL100E are 16.8±3.3 MPa, 26.6±3.9 MPa, and 34.2±2.6
MPa, respectively. Although two hydrogels (LPCL0E and LPCL50E) are significantly
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weaker than non-hydrogels in this series of materials, two hydrogels are significantly
stronger than most biodegradable hydrogels developed so far. Since LP100E, LP50E and
LP0E have similar hard segment contents, the PCL:PEG ratios in soft segments were
responsible for the differences in mechanical properties. LPCL100E, with the lowest
water retention (3.2±1.4%), exhibited the highest mechanical properties, while LPCL0E,
with the highest water retention (66.0±2.5%), exhibited the lowest mechanical properties.
Water molecules combined with PEG segments through strong hydrogen bonds
decreased the molecular force among polymer chains, thus the polymer chains mobility
were increased accordingly. As a result, the mechanical properties were decreased with
the increase of PEG content in soft segments.
Cytocompatibility Testing
To examine the cytocompatibility and cell-biomaterial interaction, chondrogenic
ATDC5 cells were cultured on the surfaces of LPCL0E, LPCL50E and LPCL100E
membranes. Cell attachment and proliferation were tested by alamarBlue assay after 7
days in culture. To obtain the maximum sensitivity of the alamarBlue assay, only a small
number of chondrocytes (1000 cells/sample; each sample was 16 mm in diameter) were
initially seeded on each material. Empty polystyrene wells were used as control.
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Figure 5: (A) alamarBlue assays on the chondrogenic cell attachment and proliferation
on LPCL0E, LPCL50E, LPCL100E and polystyrene (negative control). Chondrocytes on
hydrophilic LPCL0E and LPCL50E exhibited lower attachment and proliferation rates.
(B) alamarBlue assays of the chondrogenic cell attachment on LPCL0E and LPCL0E
with immobilized RGD in the hydrogel network (LPCL0E-RGDS hydrogel) show
significantly higher cell attachment and proliferation.
Cell attachment was examined at twenty-four hours after cell seeding. After
gently washing culture wells and changing the media, alamarBlue was added to the
culture for three hours and the number of the cells on each sample was calculated through
the conversion of the intensity of absorbance into cell numbers based on a calibration
curve obtained with a known number of ATDC5 cells. There were significant differences
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between the numbers of cells attached on the three samples (P<0.05) (Figure. 5A). As the
PEG600 content increased, the number of attached cells on the material decreases. Cells
showed the highest attachment on LPCL100E and lowest on LPCL0E, as expected. It is
well-documented that PEG can prevent protein adsorption and as well as inhibit cell
attachment, [21, 25] which allows development of biomaterials that promote desirable
cell attachment but ward off unwanted cell attachment by immobilizing a specific ligand
on the surface or into the scaffolds. [21, 25] We used Arg-Gly-Asp-Ser (RGDS) as a
model ligand to be immobilized into this series of hydrogels during the light-curing
process. We found a significant increase in cell attachment as shown in Figure 5B when
compared with the material without ligand immobilization.
There were significant differences on the cell proliferation on the three materials
as well. The proliferation rates after 7 days in culture for cells on LPCL100E, LPCL50E
and LPCL0E are 316±37%, 165±32% and 145±22% respectively, while cell numbers in
the polystyrene well increased by 452±33% (Figure 5A). The differences in cell
proliferation rate can also be observed from cell morphology images as shown in Figure
6, in which cell density on LPCL100E was much higher than on either LPCL50E or
LPCL0E. The differences in cell attachment and proliferation rate can be attributed to the
effects of PEG600 in soft segments. PEG segments tend to orient their chains to the
hydrated environment due to their high mobility in water and PEG chains readily
accumulate on the surface of materials, which then provide high excluding volume and
flexible hydrophilic chain motion to repel proteins/cells that approached the surface. It is
not surprising that cell attachment and proliferation are lower on materials with higher

70

PEG content. [22, 39] However, this can be easily overcome by immobilizing specific
ligands into the polymers (Figure 5B).
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Figure 6: Phase contrast microscopic image of chondrocytes grown on (A) polystyrene,
(B) LPCL100E, (C) LPCL50E, (D) LPCL0E, and (E) LPCL0E-RGDS after 7 days in
culture.
As shown in Figure 6, a much higher number of chondrogenic cells on the two
hydrogels, LPCL50E and LPCL0E, exhibit a rounded shape than on either LPCL100E or
polystyrene. This can probably be explained by the polymer-cell-media interactions on
the cell growth. On the surfaces of those hydrogels with the similar environment to what
chondrocytes normal reside in living tissue, mobile polymer chains can effectively
interact with large volume of water, and form a dynamic environment that limits

71

chondrocytes spreading out and therefore cells showing rounded shape in tissue or on
these hydrogels.
In-vitro Degradation

Figure 7: Schematic representation of polyurethane degradation into lysine, PCL, PEG,
HEMA, CO2 and caproic acid or lactic acid.
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Figure 8: In vitro degradation behavior of three materials at 37 °C with gentle shaking.
(A) Weight loss and (B) change in pH value of culture media .
Since this series of polymers are comprised of LDI, HEMA, PCL, and/or PEG,
the degradation process is considered to be hydrolysis of the ester groups and the
urethane groups among those polyurethanes hard and soft segments. Ester groups exist in
LDI, PCL and the urethane groups formed during the polymer synthesis, in which LDI
were polymerized with PCL, PEG and HEMA. As illustrated in Figure 7, the degradation
products of the polymerized hydrogels during hydrolysis are lysine, PEG, poly
2-hydroxyethyl methacrylate (PHEMA), carbon dioxide (CO2), and caproic acid or lactic

73

acid. All of these have been demonstrated non-toxic in humans. Attack of the water
molecules to the ester groups and urethane groups results in the weight loss of the
polymers and the environmental pH value changes due to the formation of CO2 and
organic acid. In vitro degradation rates were measured by the weight loss of the sample
films in 0.1 M PBS solution at multiple time points at 37 °C with gentle shaking to mimic
in vivo environment. pH values of the PBS solution were measured at each time point to
examine the influence of the degraded products on the culture environment. As shown in
Figure 8A, the three types of polyurethanes exhibit different degradation rates:
LPCL100E displays the slowest degradation rate while LPCL50E and LPCL0E display
faster degradation rates, which is consistent with the pH value change shown in Figure
8B. The fastest degrading polyurethane, LPCL0E, exhibits the highest pH value change
(0.41) at 4 weeks while the slowest degrading polyurethane, LPCL100E, exhibits only a
slight change (0.02) at 4 weeks. The decrease in pH is attributed to the release of small
molecules such as caproic acid or lactic acid and the dissolution of the CO2 in the PBS
solution. Since LPCL100E contains the highest ester group content in the soft segment, it
shows a lower degradation rate than LPCL50E and LPCL0E. This can be explained by
the hydrolysis mechanism of this series of polymers. Since their degradation is a
hydrolysis procedure, water penetration and diffusion will cause the hydrolysis of ester
groups and urethane groups in the polymers. Compared to LPCL50E and LPCL0E,
LP100E has lowest hydrophilicity, thus the water molecules exhibited the lowest
penetration and diffusion ability to enter the polymer chains, which results in the lowest
degradation rate during the hydrolysis process. Therefore, with the increase of the PEG
content in soft segment, the degradation rate increased significantly.
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Discussion
Cartilage is very important in load bearing and in maintaining the appropriate
shapes of many organs. Three types of cartilages can be found in the body: hyaline
cartilage lining joints, elastic cartilage found in the nasal septum, the pinna of the ear, and
the walls of the auditory and eustachian canals and larynx, and fibrocartilage found in
intervertebral disks. Many diseases lead to damage of cartilage tissue characterizing
chondrodystrophies, such as arthritis, achondroplasia, costochondritis, herniated disk, and
so on. Sports and accidents are also major causes of cartilage injuries, including meniscus
injuries, and articular cartilage damage. Due to the avascular nature of cartilage, it has
very limited capacity for self-repair, and currently, there is no treatment available to
completely regenerate damaged cartilage. For example, the mainstay treatment for
articular cartilage reconstruction is still arthrodesis (joint fusion) and arthroplasty (joint
replacement). Other approaches, such as transplantation of osteochondral allografts or
chondrocytes to replace the damaged cartilage arthroscopically and have shown improved
outcome. Approximately 95,000 total knee replacements and 41,000 other surgical
procedures to repair cartilaginous defects of the knee are performed annually in the
United States. [40] However, the repairs are far from satisfactory. Tissue engineering
cartilage by combining biomaterials and cells may present a cure for cartilage damage.
A large variety of materials, including natural and synthetic polymers, have been
investigated both in vitro and in vivo for cartilage engineering. Natural materials,
including agarose, alginate, hyaluronic acid, gelatin, fibrin glue, collagen, etc., have been
employed as porous scaffolds, fibers, microbeads, hydrogel, glue, and other forms for
cartilage repair. However, their weak mechanical properties, such as fragility, and low
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reproducibility severely limit their clinical usefulness. Synthetic materials, with the
advantages of reproducible mechanical property, tunable biochemical behavior, and
controllable degradation, were extensively investigated as well. Polymers, such as
polyester, poly(anhydrides), poly(phosphazenes), and poly(ethylene glycol) based
polymers, have been explored for cartilage engineering. Due to the hydrogel nature of
cartilage, polymers in hydrogel are form good candidates for cartilage repair, and they
have been extensively investigated in recent years. [41-49]
Due to their unique properties, hydrogels have been explored for a wide range of
biomedical applications, including drug delivery, [50], protein delivery, [51], gene
delivery, [52] wound dressing, [53] water elimination for edema, [54], cosmetic
reconstruction, [55] contact lenses, [56] and tissue engineering. [49, 57-59] One major
challenge in employing hydrogels for load-bearing connective tissue repair in cartilage,
tendon, intervertebral disk, ligament, and so on, is insufficient mechanical strength. For
instance, articular cartilage contains ~70% water and bears loads up to 100 MPa, [60] but
most hydrogels, either synthetic or derived from natural sources, can be easily broken by
pressing with a finger or pulling with the hand, indicating that they are much weaker than
native cartilage tissue. Although Stammen et al reported a poly(vinyl alcohol) (PVA)
based hydrogel with compressive modulus up to 18 MPa 61, and Gong et al developed a
double network hydrogel with a similar range of compressive modulus, [31] these
hydrogels are nondegradable and can only be used as a permanent non-physiological
replacement for damaged cartilage or a temporary solution to improve joint function and
delay total joint replacement. Gong and associates then developed a double-network
degradable hydrogel, but this had a compression modulus less than 4 MPa. [62] The
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degradable elastic hydrogels developed in this study have elastic moduli ranging from
16.8±3.3 MPa to 26.6±3.9 MPa, which are very close to the properties of native cartilage.
We expect to improve the mechanical properties when chondrocytes are cultured in these
materials and exposed to physiological dynamic forces.
The series of elastic hydrogels we described in this work are based on a backbone
of degradable polyurethane. A series of degradable polyurethanes was recently developed
for biomedical applications which had excellent mechanical properties and great
chemical versatility. [9, 12, 16, 17, 63] Elastic degradable polyurethane shows promise as
being a good candidate for most soft tissue regeneration, including cardiac muscle, [64]
blood vessel, [65, 66] skeletal muscle, tendon, ligament, and skin repair. In addition,
elastic degradable polyurethane has also been investigated for hard tissue regeneration,
such as cartilage [67] and bone tissue repair [67]. However, most currently applicable
degradable polyurethanes were based on toluene diisocyanate (TDI), methylenediphenyl
diisocyanate (MDI) or hexamethylene diisocyanate (HDI) as the hard segment and
ethylene glycol (EG) or ethylene diamine (ED) as the chain extender. These
polyurethanes were found to release toxic byproducts during degradation. For example,
MDI based polyurethanes release in vivo 4,4’-methylenedianiline which causes hepatitis
in humans. HDI, TDI and ED based polyurethanes liberate diamine during degradation
which has been proved to be toxic to the human liver and kidney. [1, 68] In recent years,
a type of diisocyanate based on lysine (LDI) has been developed for biodegradable
polyurethane synthesis. [63, 69] In these polyurethanes LDI was used as hard segment, its
degradation products in vivo were considered to be lysine and no significant toxicity or
carcinogenicity to tissue upon implantation was found. [10, 70]
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The hydrophilic nature of the PEG motifs in this series of polyurethane based
hydrogels allows protein adsorption and cell attachment to be controlled. The
immunogenicity and antigenicity are also very minimal. [40] This unique characteristic
allows fine tuning of the bioactivity of the hydrogel by selectively immobilizing specific
functional biomolecules on the surface of the hydrogel or throughout the bulk of the gel
through instant polymerization, such as UV light-induced, or through temperature
induced polymerization. [71, 72] In this study, we used RGDS as a model biomolecule
immobilized into the hydrogels, and we demonstrated increased cell attachment.
Therefore, this elastic polymer system allows for development of a bioactive hydrogel
system to selectively allow certain cell adhesion, but ward off unwanted cell attachment
by immobilizing specific bioactive molecules. In summary, our work described here can
be used as a base for developing hydrogels with precisely tunable properties for different
tissue repair.
Conclusion
In conclusion, a series of degradable polyurethane based light-curable elastic
hydrogels were synthesized from polycaprolactone diol (PCL-diol), polyethylene glycol
(PEG), lysine diisocyanate (LDI), and 2-hydroxyethyl methacrylate (HEMA) through UV
light initiated polymerization reaction. By changing the ratio of PCL to PEG during the
pre-polymer synthesis, polyurethanes with different soft segmental structures,
hydrophilicity, and cytophilicity were obtained after light-initiated polymerization. The
chemical structures of the synthesized polymers were characterized using differential
scanning calorimetry (DSC), thermogravimetric analysis (TGA) and Fourier transform
infrared spectroscopy (FTIR). Physical properties such as swelling, mechanical
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properties, and in vitro degradation were evaluated. Materials containing a higher
proportion of PEG exhibit higher water absorbance, higher degradation rate in vitro, and
lower mechanical strength in the hydrated state. Chondrocytes exhibit different
attachment and proliferation rates and different morphologies on the materials with
different PCL:PEG ratios. With a higher PEG ratio, lower cell attachment and
proliferation were observed. To improve the cell attachment and proliferation on high
PEG content hydrogels, bioactive molecules, such as peptides and proteins, could be
readily conjugated or immobilized in the gel matrix during the light-curing process. To
demonstrate that, a short peptide, Arg-Gly-Asp-Ser (RGDS), was used as a model
biomolecule and incorporated into the gels during the light-curing process, and improved
cell growth was observed. In summary, the use of PCL:PEG at different ratios, as well as
the introduction of HEMA into polyurethane, allows the synthesis of a series of
biocompatible elastic hydrogels with tunable physical and cytophilic properties through
light initiated polymerization. This series of materials also allows for controlling the cell
attachment and growth by incorporating bioactive molecules during the light-curing
process.
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CHAPTER 6
FUTURE DIRECTIONS
1. Synthesis of inter-penetrated network (IPN) of polyurethane with natural
materials such as gelatin for the improvement of the biomaterial’s cytophilicity
and mechanical properties.
2. Research on the potential of the degradable polyurethane-based highly elastic
hydrogel and a computer-controlled dynamic mini-compression bioreactor for use
in cartilage tissue engineering applications.
3. Development of polyurethane hydrogels to enable the encapsulation and sustained
release of the DNA. This DNA-polyurethane complex is expected to offer an
increased resistance to nuclease degradation and have the potential to enhance the
gene therapeutic effects in clinical application.
4. Application of polyurethane hydrogels to reduce post-surgical adhesion
formation.
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